SR Steinhubl, DL Bhatt, DM Brennan, G … - Ann Intern Med, 2009 - depts.washington.edu Background: The optimal aspirin dose for the prevention of car- diovascular
events remains controversial. ... Objective: To assess the incidence of and
risk factors for adverse clinical outcomes by investigator-determined ... Cited by 11 - Related articles - View as HTML - All 7 versions
AI Med - Annals of Internal Medicine, 2009 - Am Coll Physicians Background: The optimal aspirin dose for the prevention of car- diovascular
events remains controversial. ... Objective: To assess the incidence of and
risk factors for adverse clinical outcomes by investigator-determined ... Related articles - All 2 versions
- ►nursing2008.com AJ Furlan - Stroke, 2009 - Am Heart Assoc The combination of extended release dipyridamole and low-dose aspirin was
superior to either agent alone for secondary stroke prevention in the ESPS2 and
ESPRIT trials. This is in contradistinction to combined clopidogrel and ... Cited by 2 - Related articles - All 7 versions
M Fisher - Stroke, 2009 - Am Heart Assoc If warfarin usage alone is associated with an increased bleeding risk, what are
current estimates of the bleeding risk for warfarin plus aspirin? Using a
Medicare database, Shireman et al compared the risk of major bleeding ... Cited by 2 - Related articles - All 5 versions
JP Després - The Lancet, 2009 - Elsevier In The Lancet today, Paul Ridker and colleagues 1 present a much awaited
subanalysis from the JUPITER trial. In the initial report, 2 these investigators
tested and validated the hypothesis that asymptomatic individuals with ... Cited by 2 - Related articles - All 6 versions
PM Ridker, DH Solomon, DWR Foundation, L … - Arthritis Care & Research - interscience.wiley.com He has received consulting fees and/or lecture fees from AstraZeneca, Novartis,
Merck, Merck/Schering-Plough, Sanofi-Aventis, ISIS, Dade-Behring, and Vascular
Biogenics (less than $10,000 each) and is listed as a coinventor on patents ... Cited by 3 - Related articles - All 2 versions
R Cervera, S Bucciarelli, MA Plasín, JA … - Journal of Autoimmunity, 2009 - Elsevier The entire series includes 201 (72%) female and 79 (28%) male patients with a
mean age of 37 ± 14 years (range, 11–60 years). A total of 129 (46%) patients
suffered from primary APS, 112 (40%) from systemic lupus erythematosus, 14 ... Cited by 3 - Related articles - All 2 versions
P Prandoni, MH Prins, AWA Lensing, A … - Ann Intern Med, 2009 - Am Coll Physicians Paolo Prandoni, MD, PhD; Martin H. Prins, MD, PhD; Anthonie WA Lensing, MD, PhD;
Angelo Ghirarduzzi, MD; Walter Ageno, MD; Davide Imberti, MD; Gianluigi
Scannapieco, MD; Giovanni B. Ambrosio, MD; Raffaele Pesavento, MD; Stefano ... Cited by 5 - Related articles - All 10 versions
FA Spencer, JM Gore, G Reed, D Lessard, L … - Thrombosis and haemostasis, 2009 - ncbi.nlm.nih.gov Bleeding is the most frequent complication of antithrombotic therapy for venous
thromboembolism (VTE). However, little attention has been paid to the impact of
bleeding after VTE in the community setting. The purpose of this ... Cited by 3 - Related articles
- ►mudphudder.com [PDF] DA Garcia, DM Witt, E Hylek, AK Wittkowsky, EA … - The Annals of Pharmacotherapy, 2008 - Harvey Whitney Books STUDY SELECTION AND DATA EXTRACTION: Due to this document's scope, the medical
literature was searched using a variety of strategies. When possible,
recommendations are supported by available evidence; however, because this ... Cited by 6 - Related articles - All 6 versions
